Source: Crowdfund Insider

Taxon Biosciences: TAXA Biotechnologies Seeks $400,000 Through Title III Offering on WeFunder

On Monday, biotech startup, TAXA Biotechnologies, Inc., made history by being one of the first to use Title III rules of the JOBS Act. The company launched its initial on WeFunder with a mission to raise $400,000. Founded in 2013, TAXA Biotechnologies consists of biologists and experts who... Read MoreThe post TAXA Biotechnologies Seeks $400,000 Through Title III Offering on WeFunder appeared first on Crowdfund Insider.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Glenn Nedwin's photo - President & CEO of Taxon Biosciences

President & CEO

Glenn Nedwin

CEO Approval Rating

52/100

Read more